Pancreatic cancer (PC) is one of the most lethal cancers
worldwide,
which is usually diagnosed in the advanced stage and is highly resistant
to traditional chemotherapy, radiotherapy, and immunotherapy. Therefore,
there is an urgent need for developing new PC-specific imaging and
treatment. In this study, an quinone oxidoreductase 1 (NQO-1)-activated
near-infrared (NIR) agent, ICy-Q, was synthesized. ICy-Q is almost nonemissive, while its NIR emission at 705
nm is triggered by NQO-1-induced reduction in the PC cells. In addition,
the reduction product, ICy-OH, is specifically enriched
in mitochondria and lysosomes and acts as an effective chemotherapeutic
agent to selectively induce pancreatic cancer cell death via the cell pyroptosis pathway. Further studies have shown that ICy-Q is suitable for ex vivo imaging of
clinical PC sections and solid tumors from patients. We expect this
study will be helpful in the future for the design of targeted theranostic
agents for PC.